Recursion Pharmaceuticals Inc - Class A

1
NAS:RXRX (USA)   Class A
$ 13.37 -1.63 (-10.87%) 10:08 PM EST
At Loss
P/B:
6.58
Volume:
10.19M
Avg Vol (2M):
6.84M
Volume:
10.19M
At Loss
Avg Vol (2M):
6.84M

Business Description

Recursion Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
ISIN : US75629V1044

Share Class Description:

RXRX: Class A
Description
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Name Current Vs Industry Vs History
Cash-To-Debt 7.52
Equity-to-Asset 0.69
Debt-to-Equity 0.12
Debt-to-EBITDA -0.19
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.18
Distress
Grey
Safe
Beneish M-Score -2.42
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 57.98
9-Day RSI 60.52
14-Day RSI 60.22
6-1 Month Momentum % 13.43
12-1 Month Momentum % 35.54

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.36
Quick Ratio 4.36
Cash Ratio 4.12
Days Sales Outstanding 0.16
Days Payable 31.97

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19.3
Shareholder Yield % -0.34

Financials (Next Earnings Date:2024-02-27)

RXRX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RXRX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Recursion Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 46.928
EPS (TTM) ($) -1.46
Beta 0
Volatility % 151.19
14-Day RSI 60.22
14-Day ATR ($) 1.136876
20-Day SMA ($) 11.01475
12-1 Month Momentum % 35.54
52-Week Range ($) 4.54 - 16.745
Shares Outstanding (Mil) 215.87

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Recursion Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Recursion Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Recursion Pharmaceuticals Inc Frequently Asked Questions

What is Recursion Pharmaceuticals Inc(RXRX)'s stock price today?
The current price of RXRX is $13.37. The 52 week high of RXRX is $16.75 and 52 week low is $4.54.
When is next earnings date of Recursion Pharmaceuticals Inc(RXRX)?
The next earnings date of Recursion Pharmaceuticals Inc(RXRX) is 2024-02-27.
Does Recursion Pharmaceuticals Inc(RXRX) pay dividends? If so, how much?
Recursion Pharmaceuticals Inc(RXRX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1